检索结果-内蒙古大学图书馆

Workshop on imaging science development for cancer prevention and preemption

cancer Biomarkers 2007年第1期3卷 1-33页

作者： Kelloff, Gary J. Sullivan, Daniel C. Baker, Houston Clarke, Lawrence P. Nordstrom, Robert Tatum, James L. Dorfman, Gary S. Jacobs, Paula Berg, Christine D. Pomper, Martin G. Birrer, Michael J. Tempero, Margaret Higley, Howard R. Petty, Brenda Gumbs Sigman, Caroline C. Maley, Carlo Sharma, Prateek Wax, Adam Ginsberg, Gregory G. Dannenberg, Andrew J. Hawk, Ernest T. Messing, Edward M. Grossman, H. Barton Harisinghani, Mukesh Bigio, Irving J. Griebel, Donna Henson, Donald E. Fabian, Carol J. Ferrara, Katherine Fantini, Sergio Schnall, Mitchell D. Zujewski, Jo Anne Hayes, Wendy Klein, Eric A. DeMarzo, Angelo Ocak, Iclal Ketterling, Jeffrey A. Tempany, Clare Shtern, Faina Parnes, Howard L. Gomez, Jorge Srivastava, Sudhir Szabo, Eva Lam, Stephen Seibel, Eric J. Massion, Pierre McLennan, Geoffrey Cleary, Kevin Suh, Robert Burt, Randall W. Pfeiffer, Ruth M. Hoffman, John M. Roy, Hemant K. Wang, Thomas Limburg, Paul J. El-Deiry, Wafik S. Papadimitrakopoulou, Vali Hittelman, Walter N. MacAulay, Calum Veltri, Robert W. Solomonzz, Diane Jeronimo, Jose Richards-Kortum, Rebecca Johnson, Karen A. Viner, Jaye L. Stratton, Steven P. Rajadhyaksha, Milind Dhawan, Atam NIH/NCI/DCTD Cancer Imaging Program Bethesda MD United States NIH/NCI/DCTD Cancer Imaging Program NCI-Frederick Frederick MD United States NIH/NCI/DCP Early Detection Research Group Bethesda MD United States The Johns Hopkins University School of Medicine Departments of Radiology Pharmacology and Oncology Division of Neuroradiology Baltimore MD United States NIH/NCI/CCR Cell and Cancer Biology Branch Bethesda MD United States University of California San Francisco Department of Medicine Division of Medical Oncology San Francisco CA United States CCS Associates Inc. Mountain View CA United States Wistar Institute Molecular and Cellular Oncogenesis Program Philadelphia PA United States University of Kansas School of Medicine VA Hospital Kansas City MO United States Duke University Department of Biomedical Engineering Medical Physics Program Durham NC United States University of Pennsylvania School of Medicine Department of Gastroenterology Philadelphia PA United States New York Presbyterian Hospital Weill Medical College of Cornell University New York NY United States NIH/NCI/OD Office of Centers for Training and Resources Bethesda MD United States University of Rochester Medical Center Department of Urology Rochester NY United States University of Texas MD Anderson Cancer Center Department of Urology Houston TX United States Massachusetts General Hospital Abdominal Imaging/Interventional Radiology Boston MA United States Boston University Biomedical Engineering Electrical and Computer Engineering and Physics Boston MA United States NIH/NCI/DCP Gastrointestinal and Other Cancers Research Group Bethesda MD United States The George Washington University Cancer Institute Office of Cancer Prevention and Control Washington DC United States University of Kansas Cancer Center Clinical Oncology Kansas City KS United States University of California Davis Department of Biomedical Engineering Davis CA United States Tufts University De

The article provides information on a workshop on the development of imaging systems for cancer prevention and preemption convened by the U.S. National cancer Institute (NCI) cancer Imaging program held in Gaithersburg, Maryland. Doctor Katherine Ferrara of the University of California discussed the function of ultrasound in breast tumor imaging. Ways to close the gap between development and application of imaging approaches were tackled in a roundtable discussion on cervix and skin cancer.

关键词： FORUMS (Discussion & debate) IMAGING systems in medicine cancer prevention

来源：评论

学校读者我要写书评

暂无评论

cancer, Culture and Literacy 5th Biennial Conference: Solutions for Addressing Health Disparities through Community Partnerships: May 18—20, 2006, Clearwater Beach, Florida: Conference Highlights

引用

cancer control 2006年第4期13卷 304 - 305页

作者： Chrystyna Pospolyta Dina Martinez Janelle Menard Cathy D. Meade Division of Cancer Prevention & Control Health Outcomes & Behavior Program at the H. Lee Moffitt Cancer Center & Research Institute Tampa Florida.

来源：评论

学校读者我要写书评

暂无评论

Analysis of a Database of Materials for HIV prevention program Evaluation

引用

Health Promotion Practice 2004年第4期5卷 444-450页

作者： Davis, David Uhl, Gary Barrington, Tracey Rowel, Randy Squiers, Linda Sharp, Katherine Program Evaluation Research Branch of the Division of HIV/AIDS Prevention Centers for Disease Control and Prevention Atlanta Georgia United States Division of HIV/AIDS Prevention Centers for Disease Control and Prevention Atlanta Georgia United States Centers for Disease Control and Prevention Atlanta Georgia United States Morgan State University Public Health Program Baltimore Maryland United States Cancer Information Service Program National Cancer Institute National Institutes of Health Bethesda Maryland United States Department of Health Education and Health Promotion Kent State University Kent Ohio United States Westat in Rockville Maryland United States

program evaluation technology transfer is the transfer of information on program evaluation from research to practitioners. There have been anecdotal reports of a lack of technology transfer materials related to HIV prevention program evaluation, especially materials usable by persons without extensive training in evaluation. The Centers for Disease control and prevention reviewed available program evaluation materials relevant to HIV prevention and developed a database of those materials. Materials were classified according to appropriate audience, level of evaluation expertise required, steps in the evaluation process addressed, and other criteria. The database was queried to determine the number of materials available for various combinations of search criteria. These queries revealed that for certain audiences and steps in the evaluation process there are few materials, especially usable by individuals without evaluation experience. The conclusion is that for certain areas of program evaluation, and for certain audiences, more evaluation technology transfer materials are needed. © 2004, Sage Publications. All rights reserved.

关键词： capacity building CBO evaluation HIV prevention technical assistance technology transfer

来源：评论

学校读者我要写书评

暂无评论

Head and neck cancer committee

引用

International Journal of Radiation Oncology Biology Physics 2001年第3 SUPPL. 2期51卷 39-43页

作者： Ang, K. Weber, R. Vokes, E. Trotti, A. Chapman, D. Cooper, J. Forastiere, A. Fu, K.K. Hammond, E. Khuri, F. Leveque, F.G. Leupold, N. Eisbruch, A. Mack, C. Mukherji, S. Pajak, T.F. Ridge, J.A. Surgical Oncology Committee United States Surgical Oncology Committee United States Medical Oncology Committee United States Quality of Life Committee United States Translational Research Program Committee United States Translational Research Program Committee United States Executive Committee United States Medical Oncology Committee United States Past Committee United States Translational Research Program Committee United States Chemoprevention Committee United States Cancer Prevention and Control Program United States Patient Advocacy Committee United States Image-Guided Radiotherapy Committee United States Cancer Prevention and Control Committee United States American College of Radiology Imaging Network United States Statistician United States Surgical Oncology Committee United States

来源：评论

学校读者我要写书评

暂无评论

An adjustment to the 1997 estimate for new prostate cancer cases†

引用

cancer 2000年第9期80卷 1810-1813页

作者： Phyllis A. Wingo Ph.D., M.S. Sarah Landis M.P.H. Lynn A.G. Ries M.S. Surveillance Research Department of Epidemiology and Surveillance Research American Cancer Society Atlanta Georgia Cancer Control Research Program Division of Cancer Prevention and Control National Cancer Institute Bethesda Maryland

In light of new information, the authors present and discuss a proposed adjustment to the American cancer Society's January 1997 estimate of prostate cancer incidence rates.

关键词：

来源：评论

学校读者我要写书评

暂无评论

A comprehensive national minority intervention in tobacco control†

引用

cancer 2000年第S8期83卷 1793-1795页

作者： Roselyn Payne Epps M.D., M.P.H., M.A. Public Health Applications Branch Cancer Control Research Program Division of Cancer Prevention and Control National Cancer Institute National Institutes of Health Bethesda Maryland

Tobacco use is a major cancer risk among minorities, as evidenced by their high cancer mortality rates compared with white populations. Prior public health prevention efforts have concentrated on affecting individual behavior change through education and smoking-cessation techniques. The American Stop Smoking Intervention Study (ASSIST) project, which is sponsored by the National cancer Institute and the American cancer Society, is a 7-year research and applications project designed to demonstrate the effectiveness of coalition-based policy interventions on smoking prevention and cessation. ASSIST places major emphasis on the involvement of minority populations in this project as well as all women and youth. Minority involvement is evident through 1) representation and leadership on all levels of ASSIST policy development and administration; 2) inclusion of minority components in all national ASSIST conferences, including minority recruitment, coalition development, and sustainability design; 3) provision of specialized technical assistance and training to the 17 states by the ASSIST Coordinating Center; and 4) incorporation of minority specific activities in the various ASSIST states. Outcome evaluation of the effectiveness of the ASSIST approach will be conducted after the project's completion in 1998. However, early indicators show a marked increase in minority participation. Between 1994 and 1996, there has been an almost four-fold increase in proposed activities to reach underserved and minority communities. Most ASSIST states have formed multicultural coalitions. These results show that 1) intervention models emphasizing community-based policy activities in cancer prevention can address multicultural concerns successfully, 2) linkages with groups with similar multicultural interests increase the likelihood and success of joint cancer control efforts, and 3) policy-based interventions are more likely to have a pronounced effect on decreasing smoking and cancer

关键词： tobacco control American Stop Smoking Intervention Study multicultural populations

来源：评论

学校读者我要写书评

暂无评论

Author reply

引用

cancer 2000年第9期79卷 1847-1848页

作者： Reinhard E. Zachrau M.D. Benjamin F. Hankey Sc.D Eric J. Feuer Ph.D. Institute of Breast Diseases New York Medical College Valhalla New York Cancer Statistics Branch Surveillance Program Division of Cancer Prevention and Control National Cancer Institute Bethesda Maryland Applied Research Branch Surveillance Program Division of Cancer Prevention and Control National Cancer Institute Bethesda Maryland

来源：评论

学校读者我要写书评

暂无评论

cancer surveillance in the U.S.

引用

cancer 2000年第7期83卷 1282-1291页

作者： Judith Swan M.H.S. Phyllis Wingo Ph.D. Rosemarie Clive L.P.N. Dee West Ph.D. Daniel Miller M.D. Carol Hutchison C.T.R. Edward J. Sondik Ph.D. Brenda K. Edwards Ph.D. Cancer Surveillance Research Program Division of Cancer Control and Population Sciences National Cancer Institute Bethesda Maryland Department of Epidemiology and Surveillance Research American Cancer Society Atlanta Georgia Commission on Cancer American College of Surgeons Chicago Illinois Northern California Cancer Center Union City California National Program of Cancer Registries National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention Atlanta Georgia Cancer Registry Children's Hospital Columbus Ohio National Center for Health Statistics Centers for Disease Control and Prevention Hyattsville Maryland

cancer-related services are consuming ever-increasing health resources; along with this trend, health care costs are rising. As health care planners, researchers, and policymakers formulate strategies to meet this challenge, they are looking to cancer registries and the health information system built around them as collectors of the most extensive information regarding cancer treatment in the U.S. Currently, there are multiple programs collecting and reporting data regarding cancer incidence, morbidity, mortality, and survival. This report profiles cancer surveillance efforts in the U.S. and describes the National Coordinating Council for cancer Surveillance, which was organized in 1995 to facilitate a collaborative approach among the organizations involved. cancer 1998;83:1282-1291. © 1998 American cancer Society.

关键词： cancer control cancer registry cancer surveillance registrar

来源：评论

学校读者我要写书评

暂无评论

The dietary antioxidant network and prostate carcinoma†

引用

cancer 2000年第9期86卷 1629-1631页

作者： Steven K. Clinton M.D., Ph.D. The Cancer Prevention and Control Program The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Columbus Ohio

At this time, recommendations oncerning the use of antioxidant supplements for the prevention of prostate carcinoma should be made with great caution. More investigation of the efficacy and optimal dosing of nutrients and phytochemicals is needed. Meanwhile, an emphasis on healthy dietary and life-style patterns should be our current standard for the reduction of prostate carcinoma morbidity and mortality. See also pages 1783–92.

关键词：

来源：评论

学校读者我要写书评

暂无评论

Prognosis among African-American women and white women with lymph node negative breast carcinoma†

引用

cancer 2000年第1期80卷 80-90页

作者： James J. Dignam Ph.D. Carol K. Redmond Sc.D. Bernard Fisher M.D. Joseph P. Costantino Dr.P.H. Brenda K. Edwards Ph.D. Department of Biostatistics and National Surgical Adjuvant Breast and Bowel Project Graduate School of Public Health University of Pittsburgh Pittsburgh Pennsylvania Department of Biometry and Epidemiology College of Medicine Medical University of South Carolina Charleston South Carolina Department of Surgery and Scientific Director's Office NSABP 914 Scaife Hall University of Pittsburgh Pittsburgh Pennsylvania Cancer Control Research Program Division of Cancer Prevention and Control National Cancer Institute Bethesda Maryland

BACKGROUND A disparity in breast carcinoma survival between African-American and white women has been noted over the past several decades. A major factor implicated in this disparity is stage of disease at diagnosis. In this study, survival and related endpoints were examined among African-American women and white women with lymph node negative breast carcinoma who participated in two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). METHODS Patients from two studies, one conducted among patients with estrogen receptor (ER) negative tumors and the other among patients with ER positive tumors, were included. Study goals were to determine whether African-Americans and whites had comparable outcomes, accounting for ER status and differences in patient characteristics at diagnosis, and to determine whether treatment response was similar for African-Americans and whites. RESULTS Five-year survival rates were 83% for African-Americans and 85% for whites among ER negative patients, and 93% for African-Americans and 92% for whites among ER positive patients. Rates of disease free survival (DFS) (i.e., time to disease recurrence, second primary cancer, or death) were 71% for African-Americans and 74% for whites at 5 years among ER negative patients, and 81% for African-Americans and 80% for whites among ER positive patients. African-Americans tended to have less favorable baseline prognostic characteristics. Adjusted relative risk (RR) estimates indicated similar prognosis for African-Americans compared with whites for mortality (African-American/white RR = 1.02 with 95% confidence interval [CI], 0.66-1.56 among ER negative patients; RR = 1.14 with 95% CI, 0.84-1.54 among ER positive patients) and DFS (RR = 0.98 with 95% CI, 0.70-1.37 for ER negative patients; RR = 0.96 with 95% CI, 0.75-1.22 for ER positive patients). Estimated percent reductions in DFS events for patients receiving adjuvant therapy were 32% for ER negative Afric

关键词： Breast breast carcinoma race clinical trials hormone receptors adjuvant therapy

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：